Allergy Therapeutics (LSE:AGY) Days Sales Outstanding

: 33.43 (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

Allergy Therapeutics's average Accounts Receivable for the six months ended in Dec. 2023 was £6.15 Mil. Allergy Therapeutics's Revenue for the six months ended in Dec. 2023 was £33.57 Mil. Hence, Allergy Therapeutics's Days Sales Outstanding for the six months ended in Dec. 2023 was 33.43.

The historical rank and industry rank for Allergy Therapeutics's Days Sales Outstanding or its related term are showing as below:

LSE:AGY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 13.96 Med: 20.94 Max: 54.82
Current: 54.82

During the past 13 years, Allergy Therapeutics's highest Days Sales Outstanding was 54.82. The lowest was 13.96. And the median was 20.94.

LSE:AGY's Days Sales Outstanding is ranked better than
67.1% of 1000 companies
in the Drug Manufacturers industry
Industry Median: 72.185 vs LSE:AGY: 54.82

Allergy Therapeutics's Days Sales Outstanding increased from Dec. 2022 (32.91) to Dec. 2023 (33.43).

Allergy Therapeutics Days Sales Outstanding Historical Data

The historical data trend for Allergy Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Sales Outstanding

20.19

18.35

13.96

14.18

15.50

Allergy Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding																25.73	51.05	32.91	65.19	33.43

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Allergy Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Allergy Therapeutics Days Sales Outstanding Distribution

For the Drug Manufacturers industry and Healthcare sector, Allergy Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Allergy Therapeutics's Days Sales Outstanding falls into.

Allergy Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Allergy Therapeutics's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (2.694	+	2.366)	/	2 )	/	59.587	*	365
=	2.53					/	59.587	*	365
=	15.50

Allergy Therapeutics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (2.366	+	9.934)	/	2 )	/	33.572	*	365 / 2
=	6.15					/	33.572	*	365 / 2
=	33.43

Allergy Therapeutics (LSE:AGY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Allergy Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Allergy Therapeutics (LSE:AGY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergy Therapeutics PLC (LSE:AGY) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

HHU:Germany

Address

Dominion Way, Worthing, West Sussex, GBR, BN14 8SA

Website

https://www.allergytherapeutics.com

Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics (LSE:AGY) Headlines

No Headlines